Patients | La p147–154 group G, (n=29) | La p291–302 group F, (n=28) | La p301–318 group E, (n=33) | La p349–364 group D, (n=38) | Ro p211–232 (n=5) | Ro p169–190 (n=24) |
---|---|---|---|---|---|---|
aRo/SSA, La/SSB positive (group A, n=42) | 67 | 63 | 58 | 86 | 10 | 28 |
aRo/SSA positive (group B, n=19) | 0 | 0 | 26 | 5 | 16 | 37 |
Without aRo/SSA, La/SSB (group C, n=27) | 0 | 0 | 3 | 4 | 0 | 7 |
Normal controls (n=10) | 0 | 0 | 0 | 0 | 0 | 0 |